-
1
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: -
2
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: -
3
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: -
4
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: -
5
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: -
6
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicerad 2025Övriga upphovsmän: